Previous 10 | Next 10 |
Aurinia Pharmaceuticals (NASDAQ:AUPH) perks up 6.8% premarket after announcing positive topline results from the AURORA 2 continuation study evaluating the long-term safety and tolerability of Lupkynis (voclosporin) for the treatment of adults with active lupus nephritis (LN), a ser...
- Study demonstrated a favorable risk/benefit profile over a three-year period, with safety comparable to AURORA 1, and sustained efficacy - - Topline results show sustained meaningful reductions in proteinuria compared to mycophenolate mofetil (MMF) and low-dose oral corticosteroid...
On Tuesday, Bristol-Myers Squibb (NYSE:BMY) reached a 52-week low of $53.22. Unlike most of its large U.S. pharmaceutical company peers which are doing well in 2021, its shares are down 9.2% for the year. While Bristol's Q3 2021 revenue and profit beat Street expectations in October...
Wall Street's volatile week continued on Thursday, with stocks bouncing back after their recent losses. The rebound included a strong performance from a collection of retail names, as investors found hope in a handful of earnings reports that higher costs wouldn't necessarily obliterate margi...
Shares of the autoimmune disease specialist Aurinia Pharmaceuticals (NASDAQ: AUPH) are up by a noteworthy 15.5% as of 1:10 p.m. ET Thursday afternoon. The drugmaker's stock is perking up today in response to renewed buyout speculation. Rumors began to swirl about a possible buyo...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Investors in Express (NYSE: EXPR ) stock are celebrating on Thursday thanks to the release of the company’s Q3 2021 earnings report. Source: Helen89 / Shutterstock.com Let’s break down that earni...
Gainers: Biofrontera (NASDAQ:BFRI) +36%. CF Acquisition (NASDAQ:CFVIU) +19%. Day One (NASDAQ:DAWN) +16%. Terns Pharmaceuticals (NASDAQ:TERN) +15%. Duluth Holdings (NASDAQ:DLTH) +15%. Snowflake (NYSE:SNOW) +14%. Aurinia Pharmaceuticals (NASDAQ:AUPH) +14%. Express (NYSE:EXPR) +13%. Vor Biopharm...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Biofrontera (NASDAQ: BFRI ) stock is getting a boost on Thursday thanks to an update from the United States Patent and Trademark Office (USPTO). Source: Bukhta Yurii / Shutterstock.com According to a news rele...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Aurinia Pharma (NASDAQ: AUPH ) stock is on the rise Thursday as investors hold out hope for a takeover of the company. Source: Shutterstock.com The most recent reports claim that Novartis (NYSE: NVS ) co...
A newly detected coronavirus variant in Africa created panic and sparked a market selloff in the holiday-shortened week. However, the developers of COVID-19 vaccines and therapeutics advanced while several common stock offerings pressured decliners. Despite the outperformance of biotech stock...
News, Short Squeeze, Breakout and More Instantly...
Aurinia Pharmaceuticals Inc Company Name:
AUPH Stock Symbol:
NASDAQ Market:
Aurinia Pharmaceuticals Inc Website:
Company achieved $57.2 million in total net revenue and $55.0 million in net product revenue for the second quarter of 2024, representing year-over-year growth of approximately 38% and 34% respectively Company generated approximately $15.8 million in free cash flow in the second quarter a...
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced that it will release financial and operational results for the second quarter of 2024 on Thursday, August 1, 2024, before markets open. Aurinia’s management team will host a conference call/webcast at 8:30...
2024-06-27 04:10:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...